News

Eli Lilly Stock Soars on Weight-Loss News. Why It’s Bad for Novo Nordisk.
Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...
24/7 Wall St. on MSN15h
Here’s Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today
The Dow Jones Industrial Average is tumbling by another 440 points in midday trading today, as President Trump criticized ...
Eli Lilly’s stock soars as successful trial of weight-loss pill is a game changer
If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.
Most U.S. stocks rise, but UnitedHealth’s worst day in decades keeps Wall Street in check
Most U.S. stocks rose, but the worst drop for UnitedHealth Group in a quarter century kept Wall Street in check.
Dow Slides 500 Points As UnitedHealth Stock Heads To Worst Day In 27 Years
The UnitedHealth slide weighed heavily on the Dow, which fell 500 points, or 1.3%, Thursday morning.
Yahoo Finance2d
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
Eli Lilly (LLY) ended the recent trading session ... At the same time, the Dow lost 0.39%, and the tech-heavy Nasdaq lost 0.05%. Heading into today, shares of the drugmaker had lost 8.54% over ...
Morningstar16d
Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings — 2nd Update
Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co.'s Zepbound and generic liraglutide. The telehealth-consultation platform on Tuesday said it ...